Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Molecular Cancer Therapeutics|April 26, 2012
Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLsAli R Jazirehi, James S EconomouJournal of Immunology (Baltimore, Md. : 1950)|March 19, 2014
Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathwayAli R Jazirehi, Siavash K Kurdistani, James S EconomouCancer Immunology, Immunotherapy : CII|May 25, 2007
Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancerLisa H Butterfield, Antoni Ribas, Douglas M Potter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Current developments in cancer vaccines and cellular immunotherapyAntoni Ribas, Lisa H Butterfield, John A Glaspy, et al.Trends in Immunology|January 28, 2003
Determinant spreading and tumor responses after peptide-based cancer immunotherapyAntoni Ribas, John M Timmerman, Lisa H Butterfield, et al.Current Gene Therapy|July 12, 2002
Cancer immunotherapy using gene-modified dendritic cellsAntoni Ribas, Lisa H Butterfield, John A Glaspy, et al.Journal of Translational Medicine|April 9, 2014
Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patientsLisa H Butterfield, James S Economou, T Clark Gamblin, et al.American Journal of Clinical and Experimental Immunology|March 25, 2014
Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitorAli R Jazirehi, Ramin Nazarian, Antoni Xavier Torres-Collado, et al.Cancer Research|December 17, 2010
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interactionAli R Jazirehi, Stavroula Baritaki, Richard C Koya, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responsesLana Schumacher, Antoni Ribas, Vivian B Dissette, et al.Pageof 5